Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - TOTAL OTHER INCOME
Total Other Income ESPR - Esperion Therapeutics, Inc.
-53.7 M
LAST VALUE
-12.55%
2 YEAR CAGR
-82.68%
5 YEAR CAGR
-32.05%
10 YEAR CAGR